Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease

Circulation

Volumn 111, Issue 5, 2005, Pages 555-562

  Adams, Volker ^a   Linke, Axel ^a   Kränkel, Nicolle ^a   Erbs, Sandra ^a   Gielen, Stephan ^a   Möbius Winkler, Sven ^a   Gummert, Jan F ^a   Mohr, Friedrich Wilhelm ^a   Schuler, Gerhard ^a   Hambrecht, Rainer ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Angiotensin; Endothelium; Exercise; Polymerase chain reaction; Vessels

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; GLYCOPROTEIN GP 91; MEMBRANE PROTEIN; MESSENGER RNA; NITRIC OXIDE; PROTEIN NOX4; PROTEIN P22; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ADULT; ARTERY ENDOTHELIUM; ARTICLE; BYPASS SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; ENZYME SUBUNIT; EXERCISE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TRAINING; VASOCONSTRICTION; VASODILATATION; VASOMOTOR REFLEX;

AGED; ANGIOTENSIN II; CORONARY ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; EXERCISE; FOLLOW-UP STUDIES; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RNA, MESSENGER; SUPEROXIDES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 13444306152     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000154560.88933.7E     Document Type: Article

References (35)

1. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840-844.
2. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, Diez J. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension. 2001;38:1395-1399.
3. Hanna IR, Taniyama Y, Szocs K, Rocic P, Griendling KK. NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal. 2002;4:899-914.
4. Babior BM. NADPH oxidase: an update. Blood. 1999;93:1464-1476.
5. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494-501.
6. Cheng G, Cao Z, Xu X, Van Meir EG, Lambeth JD. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene. 2001;269:131-140.
7. Lassenge B, Sorescu D, Szöcs K, Yin Q, Akers M, Zhang Y, Gran SL, Lambeth JD, Griendling KK. Novel gp91phox homologues in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathway. Circ Res. 2001;88:888-894.
8. Sorescu D, Weiss D, Lassenge B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, Griendling KK. Superoxide production and expression of Nox family proteins in human atherosclerosis. Circulation. 2002;105:1429-1435.
9. Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, Takada J, Wakisaka M, Ibayashi S, Utsumi H, Iida M. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation. 2004;109:227-233.
10. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res. 2002;91:406-413.
11. Touyz RM, Yao G, Schiffrin EL. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2003;23:981-987.
12. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, Schiffrin EL. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res. 2002;90:1205-1213.
13. Lassenge B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol. 2003;285:R277-R297.
14. Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, Schoene N, Schuler G. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med. 2000;342:454-460.
15. Hambrecht R, Adams V, Erbs S, Linke A, Kränkel N, Shu Y, Baither Y, Gielen S, Gummert JF, Mohr FW, Schuler G. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation. 2003;107:3152-3158.
16. Hambrecht R, Schulze PC, Gielen S, Linke A, Mobius-Winkler S, Yu J, Kratzsch JJ, Baldauf G, Busse MW, Schubert A, Adams V, Schuler G. Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure. J Am Coll Cardiol. 2002;39:1175-1181.
17. Dimmeler S, Assmus B, Hermann C, Haendeler J, Zeiher A. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells. Circ Res. 1998;83:334-341.
18. Guzik JT, West EJN, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res. 2000;86:E85-E90.
19. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci. 2003;24:471-478.
20. Görlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res. 2000;87:26-32.
21. Fleming I, Michaelis UR, Bredenköter D, Fisslthaler B, Dehghani F, Brandes RP, Busse R. Endothelium-derived hyperpolarization factor synthase (Cytochrom P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res. 2001;88:44-51.
22. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003;91:7A-11A.
23. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003;111:1201-1209.
24. Kobayashi S, Inoue N, Azumi H, Hirata K, Kawashirna S, Hayashi Y, Itoh H, Yokozaki H, Yokoyama M. Expressional changes of the vascular antioxidant system in atherosclerotic coronary arteries. J Atheroscler Thromb. 2002;9:184-190.
25. Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol. 1994;266:H2568-H2572.
26. Rueckschloss U, Galle J, Holtz J, Zerkowski HR, Morawietz H. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation. 2001;104:1767-1772.
27. Hwang J, Ing MH, Salazar A, Lassenge B, Griendling K, Naveb M, Seanian A, Hsiai TK. Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation. Circ Res. 2003;93:1225-1232.
28. Nickenig G, Bäumer TA, Temur Y, Kebben D, Jockenhövel F, Böhm M. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men. Circulation. 1999;100:2131-2134.
29. Rueckschloss U, Quinn MT, Holtz J, Morawietz H. Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2002;22:1845-1851.
30. Remadi JP, Colas B, Masson H, Slama M, Andrejack M. Effect of linsidomine on the human radial artery. Clin Sci. 2002;103:1-6.
31. Ichiki T, Labosky PA, Shiota C, Okuyama S, Inagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BLM, Inagami T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature. 1995;377:748-750.
32. Hein L, Barsh GS, Bratt RE, Dzau VJ, Koblika BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2-receptor gene in mice. Nature. 1995;377:744-747.
33. Jung O, Schreiber JG, Geiger H, Pedrazzini T, Busse R, Brandes RP. Gp91phox containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation. 2004;109:1795-1801.
34. Nickenig G. Central role of the AT1-receptor in atherosclerosis. J Hum Hypertens. 2002;16:S26-S33.
35. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A. 1995;92:3521-3525.